Cellular Biomedicine Group Inc (CBMG)

[modes948]

Some Doubts Now

The bad performance, very low p/e and low volumes traded in many
Chinese companies has led EQPI.OB to take a decision to withdraw their shares from the Stock Market.They say this will save them
around $300,000 a year.

http://www.sec.gov/Archives/edgar/data/1006840/000114420411016315/v215552_pre14c.htm

I also found this on the message board of another company:

Market for Chinese IPOs in the U.S. Closed, Article Says
Posted April 14, 2011 2:14PM PST
A managing director with Rodman & Renshaw said that the market for Chinese reverse mergers and initial public offerings in the U.S. is essentially closed for business, according to an article yesterday in the South China Morning Post.
Speaking at DealFlow Media's IPO Conference 2011 in Beijing, Managing Director Brad Carlsson said that he felt "the IPO market for Chinese companies in the U.S. is now closed."
The New York-based investment bank that specializes in PIPE financings has been a major player in China.
"There are issues with reverse mergers right now. The market is extremely difficult. Investors do not want to participate," Carlsson said.
Carlsson said that the confidence that investors had developed in China during the past decade had been "worn away over the last three months."

So I hope Tsingda and Wonder are not having second thoughts about going public.Otherwise they may understandably have to postpone listing.